相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TLR4-induced IFN-γ production increases TLR2 sensitivity and drives Gram-negative sepsis in mice
Stephan Spiller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Sepsis: rethinking the approach to clinical research
John C. Marshall
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression
Thierry Roger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock
Bruno Daubeuf et al.
JOURNAL OF IMMUNOLOGY (2007)
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran
Ho Min Kim et al.
CELL (2007)
Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa
Umeharu Ohto et al.
SCIENCE (2007)
Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial
Simon Nadel et al.
LANCET (2007)
Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria
Greg Elson et al.
BLOOD (2007)
Drug therapy: Management of sepsis
Jarnes A. Russell
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effective dosing of lipid a analogue E5564 in rats depends on the timing of treatment and the route of Escherichia coli infection
SB Solomon et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1
T Roger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Crystal structure of CD14 and its implications for lipopolysaccharide signaling
JI Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Inhibition of endotoxin response by E5564, a novel toll-like receptor 4-directed endotoxin antagonist
M Mullarkey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia
M Lynn et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
MIF regulates innate immune responses through modulation of Toll-like receptor 4
T Roger et al.
NATURE (2001)
Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria
D Le Roy et al.
JOURNAL OF IMMUNOLOGY (2001)
Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism
C Werts et al.
NATURE IMMUNOLOGY (2001)
Cutting edge:: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection
O Takeuchi et al.
JOURNAL OF IMMUNOLOGY (2000)
Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis:: a randomised trial
M Levin et al.
LANCET (2000)
Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis
CW Frevert et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
